Parkside Financial Bank & Trust’s Epizyme, Inc EPZM Stock Holding History

Parkside Financial Bank & Trust’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-530	Closed	-$3K	–	1955
2021 Q3	$3K	Hold	530	–	–	﹤0.01%	1502
2021 Q2	$4K	Hold	530	–	–	﹤0.01%	1381
2021 Q1	$5K	Hold	530	–	–	﹤0.01%	1242
2020 Q4	$6K	Hold	530	–	–	﹤0.01%	1073
2020 Q3	$6K	Hold	530	–	–	﹤0.01%	905
2020 Q2	$9K	Buy	+530	New	+$9.25K	﹤0.01%	833
2020 Q1	–	Sell	-1,825	Closed	-$45K	–	1723
2019 Q4	$45K	Hold	1,825	–	–	0.01%	460
2019 Q3	$19K	Buy	1,825 +763	+72%	+$9.62K	0.01%	642
2019 Q2	$13K	Hold	1,062	–	–	﹤0.01%	759
2019 Q1	$13K	Buy	+1,062	New	+$11.9K	﹤0.01%	723

Other funds holding EPZM

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return